184 related articles for article (PubMed ID: 7510007)
1. Pharmacologic evidence for the specificity of the phosphoramidon-sensitive endothelin-converting enzyme for big endothelin-1.
Télémaque S; Gratton JP; Claing A; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S85-9. PubMed ID: 7510007
[TBL] [Abstract][Full Text] [Related]
2. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.
D'Orléans-Juste P; Lidbury PS; Telemaque S; Warner TD; Vane JR
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S251-5. PubMed ID: 1725347
[TBL] [Abstract][Full Text] [Related]
3. Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.
D'Orléans-Juste P; Télémaque S; Claing A
Br J Pharmacol; 1991 Oct; 104(2):440-4. PubMed ID: 1797310
[TBL] [Abstract][Full Text] [Related]
4. Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens.
Télémaque S; D'Orléans-Juste P
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):505-7. PubMed ID: 1766477
[TBL] [Abstract][Full Text] [Related]
5. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.
Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006
[TBL] [Abstract][Full Text] [Related]
6. Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs.
Gratton JP; Rae GA; Claing A; Télémaque S; D'Orléans-Juste P
Br J Pharmacol; 1995 Feb; 114(3):720-6. PubMed ID: 7735698
[TBL] [Abstract][Full Text] [Related]
7. Differences in potency of big endothelin-1-induced pressor action in rat isolated perfused mesenteric artery, hindquarter and lung.
Hisaki K; Matsumura Y; Fujita K; Maekawa H; Takaoka M; Morimoto S
Life Sci; 1994; 54(4):275-80. PubMed ID: 8289588
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the endothelin-converting enzyme in guinea pig upper bronchus.
Lebel N; D'Orléans-Juste P; Fournier A; Sirois P
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S81-3. PubMed ID: 8587475
[TBL] [Abstract][Full Text] [Related]
11. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
[TBL] [Abstract][Full Text] [Related]
12. Effects of phosphoramidon on endothelin-1 and big endothelin-1 production in human aortic endothelial cells.
Matsumura Y; Tsukahara Y; Kojima T; Murata S; Murakami A; Takada K; Takaoka M; Morimoto S
Biol Pharm Bull; 1995 Mar; 18(3):401-6. PubMed ID: 7550091
[TBL] [Abstract][Full Text] [Related]
13. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
Yap EY; Battistini B; McKay KO
Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
[TBL] [Abstract][Full Text] [Related]
14. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
15. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochim Biophys Acta; 1993 Feb; 1161(2-3):295-302. PubMed ID: 8431480
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery.
Schilling L; Vatter H; Mursch K; Ehrenreich H; Schmiedek P
Peptides; 2000 Jan; 21(1):91-9. PubMed ID: 10704724
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
[TBL] [Abstract][Full Text] [Related]
18. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme.
Okada K; Takada J; Arai Y; Matsuyama K; Yano M
Biochem Biophys Res Commun; 1991 Oct; 180(2):1019-23. PubMed ID: 1953706
[TBL] [Abstract][Full Text] [Related]
19. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
Held HD; Raschak M; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):619-24. PubMed ID: 9151301
[TBL] [Abstract][Full Text] [Related]
20. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway.
Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
